We report a case of mpox in a patient with a signal transducer and activator of transcription 1 gain-of-function mutation. Despite initial improvement with intravenous immune globulin and tecovirimat, severe symptoms developed and the patient died. This underscores the need for immune system optimization and effective virucidal treatments for mpox.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mayocp.2024.11.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cases of high-consequence infectious diseases identified in the UK, 1962-2023.
J Med Microbiol
March 2025
NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, UK.
The management of patients with acute infectious diseases can present significant challenges, especially if the causative agent has a propensity for person-to-person transmission. In such cases, effective patient management is dependent on both rapid identification of disease and the provision of necessary medical care while adhering to suitable infection prevention and control measures to reduce the potential for onwards transmission. The UK has operated a defined system for managing patients with high-consequence infectious diseases (HCIDs) since the 1970s, when protocols were first implemented following the first descriptions of several viral haemorrhagic fever diseases, including Marburg virus disease, Lassa fever and Ebola virus disease (EVD).
View Article and Find Full Text PDFCase report: The first case of Mpox in a patient with HIV in Burundi.
Front Med (Lausanne)
February 2025
Department of Dermatology, College of Health Sciences and Medicine, Bahir Dar University, Bahir Dar, Ethiopia.
Introduction: Mpox is a viral disease that primarily affects individuals living in endemic regions. The 2022 outbreak notably impacted HIV-positive individuals, who were disproportionately affected. This report describes the first confirmed case of Mpox in Burundi, involving an HIV-positive patient with advanced disease.
View Article and Find Full Text PDFEvidence of Mpox Clade IIb Infection in Primary Human Alveolar Epithelium.
Emerg Microbes Infect
March 2025
Division of Pharmaceutical Technology, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand 10400.
Monkeypox virus (Mpox) has been recognized for causing distinct skin lesions and is primarily transmitted through skin and sexual contact. To date, the transmissibility and pathogenesis of the Mpox virus in distal human lung has never been completely explored. Here the transmission pathways and Mpox tropism on patient-derived air-liquid epithelium (ALE) model fabricated using isolated primary human alveolar epithelial cells (hAECs) were investigated.
View Article and Find Full Text PDFMpox: exploring the nursing role in diagnosis, management and controlling its spread.
Nurs Stand
March 2025
Gay Men's Health Service, Health Service Executive, Dublin, Republic of Ireland.
Mpox, previously known as monkeypox, is a viral disease that has become a significant global health concern following outbreaks beyond its endemic regions in central and west Africa. In 2022, the World Health Organization declared a 'public health emergency of international concern' (PHEIC) due to a rise in mpox cases, predominantly affecting gay and bisexual men. Although the initial surge of cases had diminished by early 2023, a new PHEIC was declared in 2024 due to a more severe strain of the virus circulating in the Democratic Republic of the Congo.
View Article and Find Full Text PDFPrevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis.
AIDS Res Ther
March 2025
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.
Background: Vaccine acceptance among People Living with HIV (PLWH) is crucial for managing and mitigating the spread of infectious diseases, including Mpox. This systematic review and meta-analysis assess the rate of vaccine acceptance for Mpox among PLWH and identify factors influencing these rates.
Methods: We searched major databases including PubMed, Embase, and Web of Science up to 30 August 2024 for observational studies involving PLWH that reported on mpox vaccine acceptance rates.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!